• HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
Friday, January 22, 2021
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
  • HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

$5.5 million NIH grant supports new tests to diagnose dementias earlier and easier

Bioengineer by Bioengineer
October 6, 2020
in Health
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Researchers at Case Western Reserve University seek to optimize emerging methods of diagnosing two common neurodegenerative diseases — dementia with Lewy bodies and Parkinson’s disease dementia — which affect 1.4 million in the United States

IMAGE

Credit: Case Western Reserve University

With a $5.5 million, five-year award from the National Institutes of Health (NIH), researchers at Case Western Reserve University will seek to systemize new diagnostic tests for dementia with Lewy bodies and Parkinson’s disease dementia–together the second-most-common dementias after Alzheimer’s disease.

Establishing quick and reliable testing methods for these neurological conditions–using tissue samples from non-traditional sources, such as skin, nasal mucosa, or the colon–could eventually allow doctors to diagnose patients earlier and more easily.

Researchers will use real-time quaking-induced conversion (RT-QuIC), a relatively-new technology developed in Japan, to hone the identification of telltale protein deposits in areas of the body outside of where the disorders develop in the brain.

The results could eventually help doctors track the levels and distribution of the proteins–known as alpha-synuclein, or “Lewy bodies”–across tissue sites during different stages of these dementias, as well as their correlation with symptoms.

“The potential of using tissues outside the brain to assess brain disorders is highly innovative,” said Shu Chen, an associate professor of pathology and neurology at the Case Western Reserve School of Medicine. “Validating this method could have tremendous implications for more definitive diagnoses, the monitoring of disease progression–and eventually, the development of potential therapeutics for patients.”

Allison Kraus, an assistant professor in the medical school’s Department of Pathology and a neurodegenerative disease specialist, will serve as the project’s co-principal investigator with Chen, a neurobiologist and Parkinson’s disease researcher.

The two diseases are caused by the buildup of the Lewy bodies in the nerve cells of brain regions associated with memory, thinking and other mental abilities; patients can also develop tremors, lose movement and other physical symptoms.

While the clinical procedures for collecting these biospecimens–such as tiny skin punches, nasal swabs and colon biopsies–are well established, Chen, Kraus and colleagues will seek to develop high levels of diagnostic accuracy for each tissue source.

“Identifying where and when the proteins of neurodegeneration occur outside the brain will help not only with patient diagnosis, but potentially their prognosis as well,” Kraus said. “To be able to have ultrasensitive measures of disease-specific proteins in peripheral body tissues as specific and accessible biomarkers is an exciting step towards diagnosis, treatment and the development of therapeutics for these diseases.”

The medical community has long noted the presence of certain initial symptoms in patients that appear before dementias develop–including the loss of smell and constipation. In recent years, researchers have linked these dysfunctions to alpha-synuclein deposits. RT-QuIC technology has made the identification of such deposits easier and more efficient.

Lewy body dementia is often confused with other forms of dementia, such as Alzheimer’s, which is characterized by an accumulation in the brain of a different protein–known as tau–said Kraus, who is also developing tau-specific markers using RT-QuIC technology.

“The condition is frequently misdiagnosed or underdiagnosed during life,” she said. “We are seeking to differentiate Lewy body dementia from Alzheimer’s disease and other types of dementia, which could eventually improve patient care.”

###

The award is jointly funded by two divisions of NIH–the National Institute on Aging and the National Institute of Neurological Disorders and Stroke.

Also part of the team are scientists from University Hospitals Cleveland Medical Center, Cleveland Clinic Lou Ruvo Center for Brain Health in Las Vegas, NIH Rocky Mountain Laboratories and three European institutions.

  • Steven Gunzler, Brian Appleby, and Curtis Tatsuoka, from the Department of Neurology, University Hospitals Cleveland Medical Center, and Case Western Reserve University School of Medicine;
  • Xiongwei Zhu, from the Department of Pathology, Case Western Reserve University School of Medicine;
  • Clifford Harding, from the Department of Pathology, Case Western Reserve University School of Medicine, and Diagnostic Institute, University Hospitals Cleveland Medical Center;
  • Linda Cummings, Minh Lam, and Fabio Cominelli from the Cleveland Digestive Diseases Research Core Center (DDRCC), University Hospitals Cleveland Medical Center and Case Western Reserve University School of Medicine;
  • Marwan Sabbagh, Zoltan Mari, and Jiong Shi, from Cleveland Clinic Lou Ruvo Center for Brain Health in Las Vegas;
  • Byron Caughey, from NIH/NIAID Rocky Mountain Laboratories, Hamilton, Montana;
  • Gianluigi Zanusso, from University of Verona in Italy;
  • Kathrin Doppler, from University of Wurzburg in Germany; and
  • Fabio Moda, from IRCCS Istituto Neurologico C. Besta in Italy.

This project is supported by NIH grant award R01 NS118760.

Media Contact
Daniel Robison
[email protected]

Original Source

https://thedaily.case.edu/5-5-million-nih-grant-supports-new-tests-to-diagnose-dementias-earlier-and-easier/

Tags: AlzheimerDiagnosticsMedicine/Healthneurobiology
Share12Tweet8Share2ShareShareShare2

Related Posts

IMAGE

Mitochondrial mutation increases the risk of diabetes in Japanese men

January 21, 2021
IMAGE

New study: nine out of ten US infants experience gut microbiome deficiency

January 21, 2021

A new study shows the relationship between surgery and Alzheimer’s disease

January 21, 2021

Personalizing cancer care with improved tumor models

January 21, 2021
Next Post
IMAGE

Nobel Prize awarded for research with ESO telescopes on Milky Way's central black hole

IMAGE

Story Tips: Remote population counting, slowing corrosion and turning down the heat

Leave a Reply Cancel reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

POPULAR NEWS

  • IMAGE

    The map of nuclear deformation takes the form of a mountain landscape

    54 shares
    Share 22 Tweet 14
  • People living with HIV face premature heart disease and barriers to care

    64 shares
    Share 26 Tweet 16
  • New drug form may help treat osteoporosis, calcium-related disorders

    40 shares
    Share 16 Tweet 10
  • New findings help explain how COVID-19 overpowers the immune system

    35 shares
    Share 14 Tweet 9

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Tags

Climate ChangeEcology/EnvironmentMaterialsChemistry/Physics/Materials SciencesCell BiologyTechnology/Engineering/Computer ScienceBiologycancerGeneticsMedicine/HealthPublic HealthInfectious/Emerging Diseases

Recent Posts

  • New combination of immunotherapies shows great promise for treating lung cancer
  • Astronomers discover first cloudless, Jupiter-like planet
  • Advances in modeling and sensors can help farmers and insurers manage risk
  • Bringing atoms to a standstill: NIST miniaturizes laser cooling
  • Contact Us

© 2019 Bioengineer.org - Biotechnology news by Science Magazine - Scienmag.

No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

© 2019 Bioengineer.org - Biotechnology news by Science Magazine - Scienmag.

Welcome Back!

Login to your account below

Forgotten Password?

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In